Statistical Design and Considerations of a Phase 3 Basket Trial for Simultaneous Investigation of Multiple Tumor Types in One Study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Statistical Design and Considerations of a Phase 3 Basket Trial for Simultaneous Investigation of Multiple Tumor Types in One Study
Authors
Keywords
-
Journal
Statistics in Biopharmaceutical Research
Volume 8, Issue 3, Pages 248-257
Publisher
Informa UK Limited
Online
2016-06-10
DOI
10.1080/19466315.2016.1193044
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCI-MATCH Launch Highlights New Trial Design in Precision-Medicine Era:
- (2015) Caroline McNeil JNCI-Journal of the National Cancer Institute
- NCI-MATCH Launch Highlights New Trial Design in Precision-Medicine Era:
- (2015) Caroline McNeil JNCI-Journal of the National Cancer Institute
- Maximizing Return on Socioeconomic Investment in Phase II Proof-of-Concept Trials
- (2014) C. Chen et al. CLINICAL CANCER RESEARCH
- Beyond Histology: Translating Tumor Genotypes into Clinically Effective Targeted Therapies
- (2014) C. B. Meador et al. CLINICAL CANCER RESEARCH
- The dream and reality of histology agnostic cancer clinical trials
- (2014) Denis Lacombe et al. Molecular Oncology
- Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials
- (2013) Scott M Berry et al. Clinical Trials
- Evaluation of Early Efficacy Endpoints for Proof-of-Concept Trials
- (2013) Cong Chen et al. Journal of Biopharmaceutical Statistics
- Designing Transformative Clinical Trials in the Cancer Genome Era
- (2013) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Group sequential enrichment design incorporating subgroup selection
- (2013) Baldur P. Magnusson et al. STATISTICS IN MEDICINE
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Integrating predictive biomarkers and classifiers into oncology clinical development programmes
- (2011) Robert A. Beckman et al. NATURE REVIEWS DRUG DISCOVERY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- (2011) Edward S. Kim et al. Cancer Discovery
- I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
- (2009) AD Barker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Selection and bias-Two hostile brothers
- (2009) Peter Bauer et al. STATISTICS IN MEDICINE
- Optimal Cost-Effective Go-No Go Decisions in Late-Stage Oncology Drug Development
- (2009) Cong Chen et al. Statistics in Biopharmaceutical Research
- Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases
- (2008) M. C. Heinrich et al. CLINICAL CANCER RESEARCH
- Accounting for patient heterogeneity in phase II clinical trials
- (2007) J. Kyle Wathen et al. STATISTICS IN MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started